DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/3r946h/treatmenttrends) has announced the addition of Decision Resources, Inc's new report "TreatmentTrends®: European Gout Study 2011" to their offering.
TreatmentTrends® Gout in the EU is a report that covers the use of uric acid lowering (UAL) therapies as well as gout flare remedies for the treatment and management of gout among rheumatologists and primary care physicians in the E5 countries. The report focuses on current and future use of agents, patient market share, perceived strengths and weaknesses of the key UAL products, barriers to broader usage, promotional efforts and is heavy on therapies in development.
Key Topics Covered:
Background, Methods, and Objectives
- Key Findings
- Respondent Demographics
- Current Treatment Algorithms: Chronic UAL Therapy
- Current Treatment Algorithms: Acute Gout Therapy
Perceptions of UAL Product Performance
- Promotional Messaging
Evaluation of Krystexxa
Products in Development
For more information visit http://www.researchandmarkets.com/research/3r946h/treatmenttrends
Source: Decision Resources, Inc
Source: Research and Markets